95 related articles for article (PubMed ID: 7819618)
1. Preservation injury in clinical liver transplantation: incidence and effect on rejection and survival.
Katz E; Mor E; Schwartz ME; Theise N; Patel T; Miller CM
Clin Transplant; 1994 Oct; 8(5):492-6. PubMed ID: 7819618
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation.
Gaffey MJ; Boyd JC; Traweek ST; Ali MA; Rezeig M; Caldwell SH; Iezzoni JC; McCullough C; Stevenson WC; Khuroo S; Nezamuddin N; Ishitani MB; Pruett TL
Hepatology; 1997 Jan; 25(1):184-9. PubMed ID: 8985288
[TBL] [Abstract][Full Text] [Related]
3. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
Watt KD; Lyden ER; Gulizia JM; McCashland TM
Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of L-arginine against ischemia-reperfusion injury in non-heart beating rat liver graft.
Gong J; Lao XJ; Zhang SJ; Chen S
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):481-4. PubMed ID: 18842493
[TBL] [Abstract][Full Text] [Related]
5. Impact of preservation-induced liver injury on the risk of rejection of rat and human liver grafts.
Bao YM; Adam R; Farges O; Astarcioglu I; Sebagh M; Saoudi S; Bismuth H
Transplant Proc; 1995 Aug; 27(4):2502-3. PubMed ID: 7652903
[No Abstract] [Full Text] [Related]
6. Analysis of the liver effluent as a marker of preservation injury and early graft performance.
Pacheco EG; Silva OD; Sankarankutty AK; Ribeiro MA
Transplant Proc; 2010 Mar; 42(2):435-9. PubMed ID: 20304158
[TBL] [Abstract][Full Text] [Related]
7. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
[TBL] [Abstract][Full Text] [Related]
8. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation.
Killackey MT; Gondolesi GE; Liu LU; Paramesh AS; Thung SN; Suriawinata A; Nguyen E; Roayaie S; Schwartz ME; Emre S; Schiano TD
Transplant Proc; 2008 Jun; 40(5):1504-10. PubMed ID: 18589139
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatic rearterialization on reperfusion injury and outcome after mouse liver transplantation.
Steger U; Sawitzki B; Gassel AM; Gassel HJ; Wood KJ
Transplantation; 2003 Jul; 76(2):327-32. PubMed ID: 12883187
[TBL] [Abstract][Full Text] [Related]
10. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
[TBL] [Abstract][Full Text] [Related]
11. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
12. Donor age and outcome of liver transplantation.
Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
[TBL] [Abstract][Full Text] [Related]
13. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
14. Insulin in University of Wisconsin solution exacerbates the ischemic injury and decreases the graft survival rate in rat liver transplantation.
Li XL; Man K; Liu YF; Lee TK; Tsui SH; Lau CK; Lo CM; Fan ST
Transplantation; 2003 Jul; 76(1):44-9. PubMed ID: 12865784
[TBL] [Abstract][Full Text] [Related]
15. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
16. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.
Bogetti D; Sankary HN; Jarzembowski TM; Manzelli A; Knight PS; Thielke J; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
Clin Transplant; 2005 Aug; 19(4):507-11. PubMed ID: 16008596
[TBL] [Abstract][Full Text] [Related]
17. The effects of vascular bed expansion in steatotic rat liver graft viability.
Astarcioğlu H; Karademir S; Atila K; Sağol O; Koçdor H; Coker A; Astarcioğlu I
Transpl Int; 2004 May; 17(4):188-94. PubMed ID: 15107972
[TBL] [Abstract][Full Text] [Related]
18. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
[TBL] [Abstract][Full Text] [Related]
19. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning in deceased donor liver transplantation: a prospective randomized clinical trial of safety and efficacy.
Koneru B; Fisher A; He Y; Klein KM; Skurnick J; Wilson DJ; de la Torre AN; Merchant A; Arora R; Samanta AK
Liver Transpl; 2005 Feb; 11(2):196-202. PubMed ID: 15666380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
